Keensight Capital Takes Majority Stake in RAM Infotechnology

RAM Infotechnology (Keensight-backed) Acquires Interoperability Group

June 12, 2025

Healthcare Services

RAM Infotechnology (RAM-IT), supported by Keensight Capital, has acquired Interoperability Group, a Dutch provider of healthcare IT solutions headquartered in Utrecht. The acquisition adds Interoperability Group’s interoperability software, AI/data expertise and consulting capabilities to RAM-IT’s healthcare-focused cloud and managed services platform; Interoperability Group serves 200+ clients and employs more than 70 professionals.

RAM Infotechnology Acquires CuraTec with Support from Keensight Capital

July 12, 2023

Healthcare Services

RAM Infotechnology (RAM-IT), a Dutch cloud services provider for the healthcare sector and a Keensight Capital portfolio company, has acquired CuraTec, a Netherlands-based provider of healthcare alarming, alerting and communication systems. The deal strengthens RAM-IT’s healthcare IT capabilities by adding CuraTec’s alarm, sensor and network solutions to its cloud, application management and cybersecurity offerings, driving capability expansion and cross-sell opportunities in the Dutch care market.

Keensight Capital Acquires Minority Stake in e-Attestations

July 25, 2023

Cloud & SaaS

Keensight Capital has agreed to acquire a minority stake in e-Attestations, a Paris-based Third-Party Risk Management (TPRM) SaaS platform that centralizes GRC and ESG supplier data. The investment will support product development, commercial scaling and accelerate e-Attestations' international expansion, with the founder, CEO and employees co-investing alongside Keensight.

Keensight Capital Acquires Majority Stake in Symeres from Gilde Healthcare

May 25, 2021

Healthcare Services

Keensight Capital will acquire a majority stake in Symeres, a leading European small-molecule CRO and CDMO, from Gilde Healthcare with management co-investing. The investment will fund organic growth and further M&A to expand Symeres' drug discovery, development and manufacturing capabilities across Europe and globally.

Keensight Capital Acquires Majority Stake in Axxam

July 28, 2022

Biotechnology

Keensight Capital has agreed to acquire a majority stake in Axxam, an Italian innovative partner research organization (iPRO) headquartered in Milan, investing alongside Axxam's management. The sellers include current shareholders such as Bayer SpA and Zambon Company SpA; Axxam employs around 180 people and reported roughly €30 million of sales in 2021. Keensight intends to support the management team to accelerate growth and further develop Axxam's discovery capabilities.

Keensight Capital to Acquire Majority Stake in MetaCompliance

December 9, 2024

Cybersecurity

Keensight Capital has signed an exclusivity agreement to acquire a majority stake in MetaCompliance, a Northern Ireland–headquartered Human Risk Management and security awareness training software provider. Keensight will back MetaCompliance's product development, cross-selling and geographic expansion across Europe and the US while prior investor Tenzing — which previously partnered with MetaCompliance — is referenced in the announcement.